Guliani G - Search Results

1

Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.

Cheong I, Deelchand DK, Eberly LE, Marjańska M, Manousakis G, Guliani G, Walk D, Öz G. Cheong I, et al. Among authors: guliani g. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):294-301. doi: 10.1136/jnnp-2018-318795. Epub 2018 Nov 22. J Neurol Neurosurg Psychiatry. 2019. PMID: 30467209 Free PMC article.

2

Tract-specific analysis improves sensitivity of spinal cord diffusion MRI to cross-sectional and longitudinal changes in amyotrophic lateral sclerosis.

Pisharady PK, Eberly LE, Cheong I, Manousakis G, Guliani G, Clark HB, Bathe M, Walk D, Lenglet C. Pisharady PK, et al. Among authors: guliani g. Commun Biol. 2020 Jul 10;3(1):370. doi: 10.1038/s42003-020-1093-z. Commun Biol. 2020. PMID: 32651439 Free PMC article.

3

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.

Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A; REFALS investigators. Cudkowicz M, et al. Lancet Neurol. 2021 Oct;20(10):821-831. doi: 10.1016/S1474-4422(21)00242-8. Lancet Neurol. 2021. PMID: 34536404

4

Multimodal MRI improves diagnostic accuracy and sensitivity to longitudinal change in amyotrophic lateral sclerosis.

Pisharady PK, Eberly LE, Adanyeguh IM, Manousakis G, Guliani G, Walk D, Lenglet C. Pisharady PK, et al. Among authors: guliani g. Commun Med (Lond). 2023 Jun 16;3(1):84. doi: 10.1038/s43856-023-00318-5. Commun Med (Lond). 2023. PMID: 37328685 Free PMC article.

5

Occurrence of post-acute recanalization and collateral formation in patients with cerebral venous and sinus thrombosis. A serial venographic study.

Farrag A, Irfan M, Guliani GK, Tariq N, Taylor RA, Suri MF, Qureshi AI. Farrag A, et al. Among authors: guliani gk. Neurocrit Care. 2010 Dec;13(3):373-9. doi: 10.1007/s12028-010-9394-6. Neurocrit Care. 2010. PMID: 20652768

6

A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis.

Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group. Shefner JM, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11. doi: 10.1080/21678421.2019.1612922. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31081694 Clinical Trial.

7

A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis.

Shefner JM, Wolff AA, Meng L, Bian A, Lee J, Barragan D, Andrews JA; BENEFIT-ALS Study Group. Shefner JM, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):426-435. doi: 10.3109/21678421.2016.1148169. Epub 2016 Mar 16. Amyotroph Lateral Scler Frontotemporal Degener. 2016. PMID: 26982815 Clinical Trial.

8

Thompson's quadricepsplasty for stiff knee.

Kundu Z, Sangwan S, Guliani G, Siwach R, Kamboj P, Singh R. Kundu Z, et al. Among authors: guliani g. Indian J Orthop. 2007 Oct;41(4):390-4. doi: 10.4103/0019-5413.37004. Indian J Orthop. 2007. PMID: 21139797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page